Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma

NCT01601808 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Placebo
DRUG: Caprelsa (vandetanib)

Sponsor

University of Liverpool

Collaborators

[object Object]